Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T60656 | Monoamine Oxidase B inhibitor 1 | ||
Monoamine Oxidase B inhibitor 1 是一种可逆、口服有效和选择性的单胺氧化酶 B 抑制剂 (IC50 = 0.02 nM),可以穿过血脑屏障 (BBB)。Monoamine Oxidase B inhibitor 1 显示出抗氧化和抗神经炎症活性,可用于研究帕金森病。 | |||
T10079 |
MAO-IN-1
|
MAO | Metabolism; Neuroscience |
MAO-IN-1是一种高效的单胺氧化酶B (MAO B)抑制剂(IC50:20 nM),可用于研究神经系统相关疾病。 | |||
T60932 |
MAO-B-IN-8
|
MAO | Metabolism; Neuroscience |
MAO-B-IN-8是一种高效且可逆的单胺氧化酶-B(MAO-B)抑制剂,同时也能抑制微胶质细胞产生的神经炎症介质。该化合物专为神经退行性疾病相关研究而设计[1]。 | |||
T10154 |
MAO-B-IN-1
|
Others | Others |
MAO-B-IN-1 is a monoamine oxidase B inhibitor and can be used for the research of neurological diseases. | |||
T60806 | Monoamine Oxidase B inhibitor 2 | ||
Monoamine Oxidase B inhibitor 2 是有可逆并且口服有效的和选择性的单胺氧化酶 B (MAO-B) 抑制剂(IC50 = 1.33 nM) ,可以透过血脑屏障 (BBB)。Monoamine Oxidase B inhibitor 2 显示出抗氧化和抗神经炎症活性,可用于研究帕金森病。 | |||
T61463 | Monoamine oxidase/Aromatase-IN-1 | ||
Monoamine oxidase/Aromatase-IN-1 (compound 2q) is a potent dual inhibitor of monoamine oxidase (MAO) and aromatase, with IC50 values of 39 nM and 31 nM for MAO-B and aromatase, respectively. It holds significant potential for research in neurological disorders and breast cancer [1]. | |||
T79229 | ETAP | Monoamine Oxidase | Neuroscience |
ETAP为一种既抑制MAO-A也抑制MAO-B的化合物,展现出抗抑郁样活性,可应用于重度抑郁症的研究领域。 | |||
T72892 |
AChE/MAO-IN-1
|
||
AChE/MAO-IN-1 是一种有效的AChE、MAO-A 和MAO-B 抑制剂,对人 AChE、MAO-B 和MAO-A 的IC50分别为 0.0248、0.0409 和 0.1108 μM。 | |||
T61321 |
MAO-B-IN-12
|
||
MAO-B-IN-12 (Compound 16c) is a highly effective inhibitor of monoamine oxidase B (MAO-B), displaying significant potency with an IC50 value of 1.3 μM. Additionally, MAO-B-IN-12 exhibits notable neuroprotective activity [1]. | |||
T61131 |
MAO-B-IN-11
|
||
MAO-B-IN-11, also known as Compound 8c, is a highly potent inhibitor of monoamine oxidase B (MAO-B), with an IC50 value of 1.3 μM. Additionally, MAO-B-IN-11 exhibits neuroprotective properties [1]. | |||
T79761 |
MAO-B-IN-25
|
Monoamine Oxidase | Neuroscience |
MAO-B-IN-25(化合物92)作为一种选择性MAO-B抑制剂,IC50值针对MAO-A为0.5 nM,对MAO-B为240 nM。 | |||
T78821 |
IHC3
|
Monoamine Oxidase | Neuroscience |
IHC3是竞争性可逆MAO-B抑制剂(IC50:1.672 μM),能与MAO-B中的Cys172氨基酸结合,常用于神经系统疾病的研究。 | |||
T60651 |
MAO-B-IN-16
|
||
MAO-B-IN-16 是单胺氧化酶 B (MAO-B) 的选择性抑制剂 (IC 50 = 1.55 μM),可用于中枢神经疾病研究,例如帕金森病。 | |||
T78859 | MAO-B-IN-23 | Monoamine Oxidase | Neuroscience |
MAO-B-IN-23(Compound 11f)作为一种MAO-B抑制剂,具有可逆性和竞争性,其IC50为1.44 μM,Ki为0.51 μM。 | |||
T81866 |
MAO-B-IN-27
|
Monoamine Oxidase | Neuroscience |
MAO-B-IN-27(Compound 12c)是一种针对单胺氧化酶B(MAO-B)的有效且选择性的抑制剂,展现出对hMAO-B的显著抑制活性,具有8.9 nM的IC50值,用于帕金森病(PD)研究。 | |||
T78648 |
MAO-B-IN-3
|
Monoamine Oxidase | Neuroscience |
MAO-B-IN-3是一种选择性MAO-B抑制剂,具有可逆性,IC50为96 nM。该化合物还可与5-HT6R结合,Ki值为696 nM,适用于阿尔茨海默病研究。 | |||
T61830 | MAO-B-IN-10 | ||
MAO-B-IN-10 (compound 4f) is a highly potent and selective inhibitor of MAO-B (monoamine oxidase-B). It effectively penetrates the blood-brain barrier and exhibits an IC50 of 5.3 μM. This compound demonstrates the ability to inhibit self-mediated Aβ (amyloid β) aggregation by 58.2% and disaggregate it by 43.3%. Thus, MAO-B-IN-10 holds promise for Alzheimer's disease research [1]. | |||
T78848 |
MAO-IN-3
|
Monoamine Oxidase | Neuroscience |
MAO-IN-3 (Compound 5) 为一种可逆竞争性MAO抑制剂,Ki值对MAO A为0.6 μM、对MAO B为0.2 μM。该化合物能抑制LN-229胶质母细胞瘤细胞增殖,其IC50为0.8 μM,适用于癌症研究。 | |||
T78649 |
MAO-B-IN-4
|
Monoamine Oxidase | Neuroscience |
MAO-B-IN-4(Compound 26)是一款口服活性MAO-B选择性可逆抑制剂,IC50为9 nM。它展现出优良的代谢稳定性和血脑屏障渗透能力,以及在安全性方面的良好特性。此外,MAO-B-IN-4在大鼠及小鼠中表现出显著的抗抑郁效果,并在星形胶质细胞中具有神经保护作用,适用于阿尔茨海默病相关的研究。 | |||
T72453 |
AChE/BChE/MAO-B-IN-3
|
||
AChE/BChE/MAO-B-IN-3 是一种 1-茚满酮衍生物,是一种有效的MAO-B 抑制剂,对人MAO-B 的IC50为 0.0359 μM。AChE/BChE/MAO-B-IN-3 是一种有效的AChE 和BChE 酶抑制剂,对人AChE 和BChE 酶的IC50值分别为 0.0473 μM 和 0.0782 μM。AChE/BChE/MAO-B-IN-3 显示出显着的抗氧化活性,并具有用于阿尔茨海默病 (AD) 研究的潜力。 | |||
T36903 |
Rasagiline-13C3 (mesylate)
Rasagiline-13C3 (mesylate) |
||
Rasagiline-13C3is intended for use as an internal standard for the quantification of rasagiline by GC- or LC-MS. Rasagiline is an inhibitor of monoamine oxidase B (MAO-B; IC50= 4.43 nM for the rat brain enzyme).1It is selective for MAO-B over MAO-A (IC50= 412 nM for the rat brain enzyme). It inhibits serum and NGF withdrawal-induced apoptosis of PC12 cells when used at concentrations ranging from 0.01 to 100 μM.2Rasagiline inhibits rat brain MAO-Bin vivo(ED50= 0.1 mg/kg).1It reduces cerebral ede... | |||
T72454 |
AChE/BChE/MAO-B-IN-4
|
||
AChE/BChE/MAO-B-IN-4 是一种 1-茚满酮衍生物,是一种有效的MAO-B 抑制剂,对人MAO-B 的IC50为 0.0359 μM。AChE/BChE/MAO-B-IN-4 是一种有效的AChE 和BChE 酶抑制剂,对人AChE 和BChE 酶的IC50值分别为 0.0473 μM 和 0.0782 μM。AChE/BChE/MAO-B-IN-4 显示出显着的抗氧化活性,并防止β-淀粉样蛋白斑块聚集。AChE/BChE/MAO-B-IN-4 具有用于阿尔茨海默病 (AD) 研究的潜力。 |